NDC properties for NDC 9 0409-2689
NDC item 00409268901
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-01 |
| NDC Item | 00409268901 |
| packaging | 10 VIAL in 1 TRAY (0409-2689-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2689-21) |
| ANDA | ANDA065310 |
| Labeler | Hospira, Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | ACTIVE |
NDC item 00409268921
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-21 |
| NDC Item | 00409268921 |
| packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
NDC item 00409268949
| NDC 9 | 0409-2689 |
|---|---|
| NDC 10 | 0409-2689-49 |
| NDC Item | 00409268949 |
| ANDA | ANDA065241 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
NDC item 00641611601
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-01 |
| NDC Item | 00641611601 |
| packaging | 1.5 g in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
NDC item 00641611610
| NDC 9 | 0641-6116 |
|---|---|
| NDC 10 | 0641-6116-10 |
| NDC Item | 00641611610 |
| packaging | 10 VIAL in 1 CARTON (0641-6116-10) / 1.5 g in 1 VIAL (0641-6116-01) |
| ANDA | ANDA065406 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2009-12-22 |
| Marketing status | ACTIVE |
NDC item 00781303270
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-70 |
| NDC Item | 00781303270 |
| packaging | 1 in 1 VIAL |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
NDC item 00781303295
| NDC 9 | 0781-3032 |
|---|---|
| NDC 10 | 0781-3032-95 |
| NDC Item | 00781303295 |
| packaging | 10 VIAL in 1 CARTON (0781-3032-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3032-70) |
| ANDA | ANDA065241 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-07-25 |
| Marketing status | COMPLETED |
NDC item 25021014220
| NDC 9 | 25021-142 |
|---|---|
| NDC 10 | 25021-142-20 |
| NDC Item | 25021014220 |
| packaging | 10 VIAL in 1 CARTON (25021-142-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065406 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-30 |
| Marketing status | ACTIVE |
NDC item 25021018620
| NDC 9 | 25021-186 |
|---|---|
| NDC 10 | 25021-186-20 |
| NDC Item | 25021018620 |
| packaging | 10 VIAL in 1 CARTON (25021-186-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Sagent Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-03-31 |
| Marketing effective time low | 2017-08-15 |
| Marketing status | COMPLETED |
NDC item 44567021010
| NDC 9 | 44567-210 |
|---|---|
| NDC 10 | 44567-210-10 |
| NDC Item | 44567021010 |
| packaging | 10 VIAL in 1 CARTON (44567-210-10) / 10 mL in 1 VIAL |
| ANDA | ANDA065176 |
| Labeler | WG Critical Care, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-30 |
| Marketing status | ACTIVE |
NDC item 55150011601
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-01 |
| NDC Item | 55150011601 |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
NDC item 55150011610
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-10 |
| NDC Item | 55150011610 |
| packaging | 10 VIAL in 1 CARTON (55150-116-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
NDC item 55150011620
| NDC 9 | 55150-116 |
|---|---|
| NDC 10 | 55150-116-20 |
| NDC Item | 55150011620 |
| packaging | 10 VIAL in 1 CARTON (55150-116-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA090349 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-02-10 |
| Marketing status | ACTIVE |
NDC item 55150017899
| NDC 9 | 55150-178 |
|---|---|
| NDC 10 | 55150-178-99 |
| NDC Item | 55150017899 |
| packaging | 10 BOTTLE in 1 BOX (55150-178-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
| ANDA | ANDA090340 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-09-13 |
| Marketing status | ACTIVE |
NDC item 63323036820
| NDC 9 | 63323-368 |
|---|---|
| NDC 10 | 63323-368-20 |
| NDC Item | 63323036820 |
| packaging | 10 VIAL in 1 CARTON (63323-368-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA065222 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | COMPLETED |
NDC item 66794020602
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-02 |
| NDC Item | 66794020602 |
| packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
NDC item 66794020641
| NDC 9 | 66794-206 |
|---|---|
| NDC 10 | 66794-206-41 |
| NDC Item | 66794020641 |
| packaging | 10 VIAL in 1 CARTON (66794-206-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-206-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | COMPLETED |
NDC item 66794024102
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-02 |
| NDC Item | 66794024102 |
| packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
NDC item 66794024141
| NDC 9 | 66794-241 |
|---|---|
| NDC 10 | 66794-241-41 |
| NDC Item | 66794024141 |
| packaging | 10 VIAL in 1 CARTON (66794-241-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-241-02) |
| ANDA | ANDA090579 |
| Labeler | Piramal Critical Care Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-12-31 |
| Marketing effective time low | 2023-01-01 |
| Marketing status | DROPPED |
NDC item 67457034810
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-10 |
| NDC Item | 67457034810 |
| packaging | 10 VIAL in 1 CARTON (67457-348-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
NDC item 67457034815
| NDC 9 | 67457-348 |
|---|---|
| NDC 10 | 67457-348-15 |
| NDC Item | 67457034815 |
| packaging | 1 VIAL in 1 CARTON (67457-348-15) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-10-31 |
| Marketing effective time low | 2014-04-08 |
| Marketing status | COMPLETED |
NDC item 70594008101
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-01 |
| NDC Item | 70594008101 |
| packaging | 1 in 1 VIAL |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
NDC item 70594008102
| NDC 9 | 70594-081 |
|---|---|
| NDC 10 | 70594-081-02 |
| NDC Item | 70594008102 |
| packaging | 10 VIAL in 1 CARTON (70594-081-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-081-01) |
| ANDA | ANDA090579 |
| Labeler | Xellia Pharmaceuticals USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-12-31 |
| Marketing effective time low | 2021-01-10 |
| Marketing status | COMPLETED |
NDC item 71288000520
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-20 |
| NDC Item | 71288000520 |
| packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-005-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-005-21) |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
NDC item 71288000521
| NDC 9 | 71288-005 |
|---|---|
| NDC 10 | 71288-005-21 |
| NDC Item | 71288000521 |
| packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-07-31 |
| Marketing effective time low | 2022-01-17 |
| Marketing status | COMPLETED |
NDC item 71288003120
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-20 |
| NDC Item | 71288003120 |
| packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
NDC item 71288003121
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-21 |
| NDC Item | 71288003121 |
| packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-20) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
NDC item 71288003191
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-91 |
| NDC Item | 71288003191 |
| packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
NDC item 71288003192
| NDC 9 | 71288-031 |
|---|---|
| NDC 10 | 71288-031-92 |
| NDC Item | 71288003192 |
| packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-91) |
| ANDA | ANDA065222 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-29 |
| Marketing status | ACTIVE |
NDC item 72485041601
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-01 |
| NDC Item | 72485041601 |
| packaging | 1 in 1 VIAL |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
NDC item 72485041610
| NDC 9 | 72485-416 |
|---|---|
| NDC 10 | 72485-416-10 |
| NDC Item | 72485041610 |
| packaging | 10 VIAL in 1 CARTON (72485-416-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-416-01) |
| ANDA | ANDA201024 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| Labeler | Armas Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-07-21 |
| Marketing status | ACTIVE |
NDC item 72572002101
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-01 |
| NDC Item | 72572002101 |
| packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
NDC item 72572002110
| NDC 9 | 72572-021 |
|---|---|
| NDC 10 | 72572-021-10 |
| NDC Item | 72572002110 |
| packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-021-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-021-01) |
| ANDA | ANDA090579 |
| Labeler | Civica, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-10 |
| Marketing status | COMPLETED |
NDC item 72603022001
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-01 |
| NDC Item | 72603022001 |
| packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
NDC item 72603022010
| NDC 9 | 72603-220 |
|---|---|
| NDC 10 | 72603-220-10 |
| NDC Item | 72603022010 |
| packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-220-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | NorthStar Rx, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-01 |
| Marketing status | ACTIVE |
NDC item 82449051301
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-01 |
| NDC Item | 82449051301 |
| packaging | 1 VIAL in 1 CARTON (82449-513-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
NDC item 82449051302
| NDC 9 | 82449-513 |
|---|---|
| NDC 10 | 82449-513-02 |
| NDC Item | 82449051302 |
| packaging | 10 VIAL in 1 CARTON (82449-513-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA201024 |
| Labeler | Steriscience Specialties Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-14 |
| Marketing status | ACTIVE |
NDC item 83634010920
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-20 |
| NDC Item | 83634010920 |
| packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (83634-109-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (83634-109-41) |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |
NDC item 83634010941
| NDC 9 | 83634-109 |
|---|---|
| NDC 10 | 83634-109-41 |
| NDC Item | 83634010941 |
| packaging | 1 in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA065222 |
| Labeler | Avenacy, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-01 |
| Marketing status | ACTIVE |